BMC (BioMed Central)

Advances in Rheumatology Template

Write in a clean editor, then format for Advances in Rheumatology in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Advances in Rheumatology format

Advances in Rheumatology is a peer-reviewed journal published by BMC (BioMed Central), covering Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Systemic Lupus Erythematosus Research. Over its lifetime it has published 552 papers, which have received 6,200 citations.

PublisherBMC (BioMed Central)
Reference styleNumbered (Vancouver)
Numbered — [1], [2] in the text
1. Smith A, Jones B, Lee C. A representative article title. Advances in Rheumatology. 2023;12(3):45–58.

Formats any DOI in Advances in Rheumatology style. No sign-up.

Publishes research inRheumatoid Arthritis Research and Therapies Spondyloarthritis Studies and Treatments Systemic Lupus Erythematosus Research Autoimmune and Inflammatory Disorders Research Systemic Sclerosis and Related Diseases
ISSN2523-3106
Citation impact (2-yr)2.8
h-index37
i10-index197
Open accessYes — indexed in DOAJ
Top institutions publishing hereUniversidade Federal de São Paulo
Journal websitelink.springer.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Advances in Rheumatology per year

43
2018
63
2019
50
2020
74
2021
49
2022
58
2023
92
2024
76
2025

Citation impact of Advances in Rheumatology by publication year

1.1K
2018
1.6K
2019
979
2020
1K
2021
447
2022
430
2023
483
2024
86
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Advances in Rheumatology

Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis

Sara de Brito Rocha, Danielle Cristiane Baldo, Luís Eduardo Coelho Andrade · 17 Jan 2019

Rheumatoid arthritis (RA) is an autoimmune/inflammatory disease affecting 0.5 to 1% of adults worldwide and frequently leads to joint destruction and disability. Early diagnosis and early and effective therapy may prevent joint damage and lead to better long-term results. Therefore, reliable biomarkers and outcome measures are needed. Refinement of the understanding of molecular pathways involved…

Benzbromarone in the treatment of gout

Valderílio Feijó Azevedo, Igor Age Kos, Ana Beatriz Vargas‐Santos et al. · 7 Aug 2019

BACKGROUND: Benzbromarone is a uricosuric drug that has been used in the treatment of gout over the last 30 years. Due to its potent inhibition of the dominant apical (luminal) urate exchanger in the human proximal tubule URAT1, it reduces the urate reabsorption, diminishing serum urate levels and therefore preventing gout flares. Through several clinical…

A cross-sectional study of associations between kinesiophobia, pain, disability, and quality of life in patients with chronic low back pain

Josielli Comachio, Maurício Oliveira Magalhães, Ana Paula Carvalho‐e‐Silva et al. · 21 Jun 2018

BACKGROUND: Low back pain is a significant health problem condition due to high prevalence among the general population. Emotions and physical factors are believed to play a role in chronic low back pain. Kinesiophobia is one of the most extreme forms of fear of pain due to movement or re-injury. The purpose of this study…

Revisiting hydroxychloroquine and chloroquine for patients with chronic immunity-mediated inflammatory rheumatic diseases

Edgard Torres dos Reis Neto, Adriana María Kakehasi, Marcelo Antônio Amaro Pinheiro et al. · 9 Jun 2020

Hydroxychloroquine and chloroquine, also known as antimalarial drugs, are widely used in the treatment of rheumatic diseases and have recently become the focus of attention because of the ongoing COVID-19 pandemic. Rheumatologists have been using antimalarials to manage patients with chronic immune-mediated inflammatory rheumatic diseases for decades. It is an appropriate time to review their…

Burden of rheumatoid arthritis on patients’ work productivity and quality of life

Ricardo Machado Xavier, Cristiano A. F. Zerbini, Daniel Feldman Pollak et al. · 9 Nov 2019

BACKGROUND: To determine the burden of Rheumatoid Arthritis (RA) on patients' work productivity and health related quality of life (HRQoL), and examine the influence of several exposure variables; to analyze the progression of RA over 1 year and its impact on work productivity and HRQoL. METHODS: International multicenter prospective survey including patients in 18 centers…

Advances in Rheumatology template — frequently asked questions

How do I write a paper in the Advances in Rheumatology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Advances in Rheumatology template. When you export, DocuGuru compiles the paper into the official BMC (BioMed Central) format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Advances in Rheumatology use?
Advances in Rheumatology uses Numbered (Vancouver) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith A, Jones B, Lee C. A representative article title. Advances in Rheumatology. 2023;12(3):45–58.
Do I need to know LaTeX to submit to Advances in Rheumatology?
No. DocuGuru generates the bmcart LaTeX class and compiles the PDF for you in the background, so you get a BMC (BioMed Central)-ready Advances in Rheumatology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Advances in Rheumatology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Advances in Rheumatology format with correct headings, figures, tables, and numbered citations.
What is Advances in Rheumatology?
BMC / BioMed Central journal. It is a life sciences and medicine journal, published by BMC (BioMed Central).
Can I export a submission-ready Advances in Rheumatology PDF?
Yes — DocuGuru produces a PDF built with the official Advances in Rheumatology template (the bmcart class) that is ready to submit to BMC (BioMed Central), together with the matching LaTeX source files.
How much does the Advances in Rheumatology template cost?
You can start writing in the Advances in Rheumatology template for free. Exporting the final submission-ready Advances in Rheumatology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Advances in Rheumatology template